https://www.selleckchem.com/pr....oducts/Adrucil(Fluor
Tolerance was very satisfactory, with a low occurrence of infections. Regarding efficacy, only one patient treated with APR did not achieve any notable clinical improvement. Despite supportive data regarding tolerance, the heterogeneity of the analyzed population and limited available data, BT and APR should be used with caution in this patient population and investigations on larger cohorts should be conducted to further assess their tolerance in this patient population. Despite supportive data regarding tolerance, the he
Beğen
Yorum Yap
Paylaş
